Literature DB >> 16099387

Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics.

Michael Maceyka1, Sheldon Milstien, Sarah Spiegel.   

Abstract

It has become abundantly clear over the past decade that sphingolipids and their metabolites are key signaling molecules. Ceramide, the backbone of all sphingolipids, predominantly inhibits cell growth and induces apoptosis, while its metabolite, sphingosine-1-phosphate promotes growth and survival. Given the interconvertibility of these two opposing signaling molecules, it is essential that any study that examines the effects of one also look at the other. The newly available technology of liquid chromatography-tandem mass spectroscopy (LC-MS/MS) is increasingly being applied for this purpose, as it can quickly identify and measure many different sphingolipids simultaneously. An added benefit of LC-MS/MS is that it is several orders of magnitude more sensitive than enzymatic methods or more traditional chromatographic techniques, allowing smaller sample sizes and increased throughput. Here, we briefly discuss the importance of LC-MS/MS for measuring sphingolipid metabolites and some future directions researchers may take given the increasingly accessibility to this technology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099387     DOI: 10.1016/j.prostaglandins.2004.09.010

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  16 in total

1.  Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.

Authors:  Masayuki Nagahashi; Kazuaki Takabe; Runping Liu; Kesong Peng; Xiang Wang; Yun Wang; Nitai C Hait; Xuan Wang; Jeremy C Allegood; Akimitsu Yamada; Tomoyoshi Aoyagi; Jie Liang; William M Pandak; Sarah Spiegel; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

4.  Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.

Authors:  Jamie Cantrell Stanford; Andrew J Morris; Manjula Sunkara; Gabriel J Popa; Kara L Larson; Sabire Özcan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

5.  Substrate specificity, membrane topology, and activity regulation of human alkaline ceramidase 2 (ACER2).

Authors:  Wei Sun; Junfei Jin; Ruijuan Xu; Wei Hu; Zdzislaw M Szulc; Jacek Bielawski; Lina M Obeid; Cungui Mao
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

6.  A review of lipidomic technologies applicable to sphingolipidomics and their relevant applications.

Authors:  Xianlin Han; Xuntian Jiang
Journal:  Eur J Lipid Sci Technol       Date:  2009       Impact factor: 2.679

7.  Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition.

Authors:  Jeremy A Hengst; Jacquelyn M Guilford; Todd E Fox; Xujun Wang; Elizabeth J Conroy; Jong K Yun
Journal:  Arch Biochem Biophys       Date:  2009-09-24       Impact factor: 4.013

8.  Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Authors:  Angela M Whetzel; David T Bolick; Catherine C Hedrick
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-17       Impact factor: 4.249

9.  Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice.

Authors:  Sang Won Park; Mihwa Kim; Sean W C Chen; Vivette D D'Agati; H Thomas Lee
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

10.  Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation.

Authors:  Natalia M Grin'kina; Eddy E Karnabi; Dushyant Damania; Sunil Wadgaonkar; Ilham A Muslimov; Raj Wadgaonkar
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.